Another Player in Advanced Bladder Cancer
Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy
Related Articles
Opinion | Men Too: Sexual Harassment in the Operating Room
The fear and anxiety that come with harassment cross all boundaries
Could Francis Collins’s Prostate Cancer Story Deter Men From Active Surveillance?
Experts suggest his apparent situation is rare
Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Foretelling the Future of Early NSCLC Recurrence With Machine Learning
Could machine learning be the
PAs in Oregon Can Soon Use ‘Physician Associate’ Title
New law to take effect in June; rebranding effort is years in the making
For PCI, Intravascular Ultrasound Guidance Bests Angiography Guidance
Randomized trial shows better outcomes for patients with acute coronary syndromes
Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis
Small study suggested benefits for MS patients with chronic optic neuropathy
Should DOs and MDs Have Separate Licensing Boards? They Still Do in 13 States
West Virginia effort hits late obstacle; some DOs fear bias under a combined board
Doctors Strike at Detroit Hospital After Unionizing Last Year
Emergency physicians, contracted through TeamHealth, have pointed to staffing, quality concerns
